Trusted News Discovery Since 2008
{{/content}}
Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine
Video Credit: WJZ Baltimore
Published on July 29, 2021 - Duration: 00:37s
Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine
The FDA announced that they will allow Emergent BioSolutions to resume production of the Johnson and Johnson covid-19 vaccine on Thursday.
You are here
Related videos from verified sources
Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine 00:31
Video credit: WJZ Baltimore - Published on July 29, 2021